주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-04-26 16:52 (Fri)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
All articles
목록
(
총 :
345 )
기사목록 보기 형태
제목형
요약형
포토형
Gilead’s Genvoya comfortably tops HIV treatments
Nam Doo-hyun
2018.08.24 14:17
3 multinationals refuse to take pharma group’s anti-corruption system
Nam Doo-hyun
2018.08.23 11:18
Foreign CEOs to lead Korean units of Novartis, Galderma
Nam Doo-hyun
2018.08.22 13:38
[Special] Pharmaceuticals at odds with government over selective benefit system
Nam Doo-hyun
2018.08.21 15:29
Korea narrows gap with Japan in healthcare IoT patents
Nam Doo-hyun
2018.08.16 15:40
[Reporter’s Notebook] Is Korean market unimportant for Samsung Bioepis?
Nam Doo-hyun
2018.08.16 14:18
Local patents increasingly target obesity
Nam Doo-hyun
2018.08.14 15:44
Who will be first to develop new acute pancreatitis remedy?
Nam Doo-hyun
2018.08.14 10:22
Bio stock slump drags down diagnostics, equipment, reagent companies
Nam Doo-hyun
2018.08.09 14:26
‘Bayer’s liver cancer drug better than expected’
Nam Doo-hyun
2018.08.06 17:57
2018-listed pharmaceutical, medical shares tank
Nam Doo-hyun
2018.07.31 13:54
Patent approved to predict chemotherapeutic effects for breast cancer patients
Nam Doo-hyun
2018.07.27 11:44
처음
이전
이전
1
2
3
4
5
6
7
8
9
10
다음
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기